Pricing Log in Create free account

NRx Pharmaceuticals, Inc. (NRXP) vs Seer, Inc. (SEER)

NRx Pharmaceuticals, Inc. and Seer, Inc. are both Biotechnology companies. NRx Pharmaceuticals, Inc. and Seer, Inc. are of similar size ($117.3M and $113.0M). Seer, Inc. has the higher net margin (−478.1% vs −691.8%) and the lower return on invested capital (−60.8% vs 0.00%). Across the 15 metrics below, Seer, Inc. leads on 8 and NRx Pharmaceuticals, Inc. on 7.

Valuation

Metric NRXP SEER Biotechnology median
P/E n/m n/m 8.50
P/S 28.84 7.88 9.71
P/B n/m 0.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.64 0.64
EV/Sales 22.58 (2.87) 9.21
Earnings yield (21.15%) (60.10%) (33.15%)
Free cash flow yield (21.12%) (39.27%) (25.50%)

Profitability

Metric NRXP SEER Biotechnology median
Gross margin 46.64% 47.70% 65.16%
Operating margin (586.15%) (498.19%) 0.00%
Net margin (691.78%) (478.05%) 0.00%
Free cash flow margin (609.02%) (309.34%) 0.00%
Return on equity 131.22% (26.45%) (56.36%)
Return on assets (120.41%) (23.47%) (48.04%)
Return on invested capital 0.00% (60.78%) 0.00%

Growth

Metric NRXP SEER Biotechnology median
Revenue growth (TTM) — (12.71%) 6.02%
EPS growth (last fiscal year) 43.22% 7.91% 30.26%
Revenue growth, 5-year CAGR — 90.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXP SEER Biotechnology median
Debt to equity (2.42) 0.00 0.00
Current ratio 0.86 14.74 4.72
Net debt to EBITDA 0.48 2.63 0.96

Dividend

Metric NRXP SEER Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NRXP SEER Biotechnology median
Market cap 117.34m 112.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack